ADAR1 Capital Management »

Stevanato Group S P A shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Stevanato Group S P A (STVN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Stevanato Group S P A

Tip: Access up to 7 years of quarterly data

All positions including Stevanato Group S P A held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stevanato Group S P A by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $498k 16k 32.10

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Stevanato Group S P A

Conestoga Capital Advisors
Neuberger Berman Group
T. Rowe Price Investment Management
Thrivent Financial for Lutherans
Jackson Square Partners
Artisan Partners Limited Partnership
Lazard Asset Management
Sands Capital Management
Bamco
TimesSquare Capital Management
Alliancebernstein
Deutsche Bank Aktiengesellschaft
Riverbrige Partners
Fred Alger Management
Pembroke Management

View all funds holding Stevanato Group S P A